Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People With Type 1 Diabetes

NCT07427251 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT07427251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07427251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Glucagon and Automated Insulin Delivery for Prevention of Spontaneous Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Phase 4
Overall status
Recruiting
Start date
April 27, 2026
Completion date
May 1, 2028
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus